Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma

In Vivo. 2021 May-Jun;35(3):1611-1615. doi: 10.21873/invivo.12418.

Abstract

Background/aim: Oncogene up-regulation combined with suppressor gene down-regulation is a crucial genetic combination that promotes cell neoplastic phenotype and progressively malignant transformation in solid malignancies, including laryngeal squamous cell carcinoma (LSCC). Among oncogenes, the Kirsten ras oncogene homolog (K-Ras) is involved in LSCC onset and progression.

Patients and methods: Sixty (n=60) primary LSCC tissue sections were analyzed by immunohistochemistry (IHC). Digital image analysis (DIA) was also implemented for measuring K-Ras protein expression levels.

Results: High K-Ras protein expression levels were observed in 20/60 (33.3%) LSCC tissue sections, whereas the rest of the cases (n=40; 66.7%) demonstrated low expression. Overall K-Ras expression was borderline significantly associated to the grade of the examined malignancies (p=0.048), whereas no other strong statistical correlations were identified. A progressive K-Ras overexpression was observed in all grades of the examined cases.

Conclusion: K-Ras over expression is correlated to a progressive dedifferentiation in LSCC.

Keywords: Carcinoma; K-Ras; larynx; oncogene.

MeSH terms

  • Carcinoma, Squamous Cell* / genetics
  • Gene Expression Regulation, Neoplastic
  • Genes, ras
  • Head and Neck Neoplasms*
  • Humans
  • Laryngeal Neoplasms* / genetics
  • Proto-Oncogene Proteins p21(ras)
  • Squamous Cell Carcinoma of Head and Neck

Substances

  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)